- Home
- ITT vs SMMT Comparison
ITT vs SMMT Comparison
Compare ITT & SMMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITT
- SMMT
- Stock Information
- Founded
- ITT 1920
- SMMT 2003
- Country
- ITT United States
- SMMT United States
- Employees
- ITT N/A
- SMMT N/A
- Industry
- ITT Fluid Controls
- SMMT Biotechnology: Pharmaceutical Preparations
- Sector
- ITT Industrials
- SMMT Health Care
- Exchange
- ITT Nasdaq
- SMMT Nasdaq
- Market Cap
- ITT 12.4B
- SMMT 14.5B
- IPO Year
- ITT N/A
- SMMT N/A
- Fundamental
- Price
- ITT $155.41
- SMMT $18.42
- Analyst Decision
- ITT Strong Buy
- SMMT Strong Buy
- Analyst Count
- ITT 9
- SMMT 4
- Target Price
- ITT $157.89
- SMMT $34.75
- AVG Volume (30 Days)
- ITT 441.1K
- SMMT 2.1M
- Earning Date
- ITT 10-29-2024
- SMMT 10-30-2024
- Dividend Yield
- ITT 0.82%
- SMMT N/A
- EPS Growth
- ITT 11.49
- SMMT N/A
- EPS
- ITT 5.85
- SMMT N/A
- Revenue
- ITT $3,530,800,000.00
- SMMT N/A
- Revenue This Year
- ITT $11.61
- SMMT N/A
- Revenue Next Year
- ITT $7.15
- SMMT N/A
- P/E Ratio
- ITT $26.59
- SMMT N/A
- Revenue Growth
- ITT 9.36
- SMMT N/A
- 52 Week Low
- ITT $107.01
- SMMT $1.89
- 52 Week High
- ITT $156.00
- SMMT $33.89
- Technical
- Relative Strength Index (RSI)
- ITT 62.91
- SMMT 43.10
- Support Level
- ITT $149.65
- SMMT $18.11
- Resistance Level
- ITT $154.15
- SMMT $20.14
- Average True Range (ATR)
- ITT 3.01
- SMMT 1.40
- MACD
- ITT 0.37
- SMMT -0.22
- Stochastic Oscillator
- ITT 96.33
- SMMT 8.67
About ITT ITT Inc.
ITT Inc is a diversified manufacturer of engineered critical components and customized technology solutions predominantly for the transportation, industrial and energy markets. The company's products include, brake pads, shock absorbers, pumps, valves, connectors, switches and others. Its operating segments are; Motion Technologies (MT), Industrial Process (IP), and Connect & Control Technologies (CCT). The majority of the revenue is generated from the Motion Technologies segment which is a manufacturer of brake pads, shims, shock absorbers, energy absorption components and sealing technologies. Geographically, the company generates majority of the revenue from North America, and also has its presence in South America, Europe, Asia, Middle East and Africa.
About SMMT Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.